Daily Care for March 17, 2021
advertisement
- Type 1 diabetes in Finland: past, present, and future (HTML)
- Use it or lose it. The hidden price of diabetes technologies
- Impact of lockdown during COVID-19 emergency on glucose metrics of children and adolescents with type 1 diabetes in Piedmont, Italy (HTML)
- Text message reminders for adolescents with poorly controlled type 1 diabetes: A randomized controlled trial (HTML)
- How adults with type 1 diabetes are navigating the challenges of open-source artificial pancreas systems: a qualitative study (HTML)
- Multi-Timescale Rhythmicity of Blood Glucose and Insulin Delivery Reveals Key Advantages of Hybrid Closed Loop Therapy (HTML)
- Racial Disparities in Diabetes Technology Use and Outcomes in Type 1 Diabetes in a Safety-Net Hospital (HTML)
- Insulin therapy in childhood type 1 diabetes: Knowledge and practice in Senegal (HTML)
- Outpatient clinic-wide psychological screening for children and adolescents with type 1 diabetes in Qatar: An initiative for integrative healthcare in the Gulf region (HTML)
- Comparison of Clinical and Social Characteristics of Canadian Youth Living With Type 1 and Type 2 Diabetes (HTML)
- Ecological momentary assessment for health behaviors and contextual factors in persons with diabetes: A systematic review (HTML)
- Association between physical activity level and cardiovascular risk factors in adolescents living with type 1 diabetes mellitus: a cross-sectional study (HTML)
- HbA1c and BMI after lockdown for COVID-19 in children and adolescents with type 1 diabetes mellitus (HTML)
- Trends in Factors Affecting Pregnancy Outcomes Among Women With Type 1 or Type 2 Diabetes of Childbearing Age (2004-2017) (HTML)
- Improved Postprandial Glucose Control With Ultra Rapid Lispro Versus Lispro With Continuous Subcutaneous Insulin Infusion in Type 1 Diabetes: PRONTO-Pump-2 (HTML)
- Bariatric surgery in the treatment of patients with obesity and type 1 diabetes – a retrospective study of clinical data (HTML)
- High HbA1c in type 1 diabetes linked to increased risk for neurodevelopment disorders
